Correlation Between Genovis AB and Combigene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovis AB and Combigene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovis AB and Combigene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovis AB and Combigene AB, you can compare the effects of market volatilities on Genovis AB and Combigene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovis AB with a short position of Combigene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovis AB and Combigene.

Diversification Opportunities for Genovis AB and Combigene

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Genovis and Combigene is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Genovis AB and Combigene AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Combigene AB and Genovis AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovis AB are associated (or correlated) with Combigene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Combigene AB has no effect on the direction of Genovis AB i.e., Genovis AB and Combigene go up and down completely randomly.

Pair Corralation between Genovis AB and Combigene

Assuming the 90 days trading horizon Genovis AB is expected to generate 0.82 times more return on investment than Combigene. However, Genovis AB is 1.22 times less risky than Combigene. It trades about 0.11 of its potential returns per unit of risk. Combigene AB is currently generating about 0.01 per unit of risk. If you would invest  2,300  in Genovis AB on April 23, 2025 and sell it today you would earn a total of  345.00  from holding Genovis AB or generate 15.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Genovis AB  vs.  Combigene AB

 Performance 
       Timeline  
Genovis AB 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Genovis AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Genovis AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
Combigene AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Combigene AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Combigene is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Genovis AB and Combigene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovis AB and Combigene

The main advantage of trading using opposite Genovis AB and Combigene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovis AB position performs unexpectedly, Combigene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Combigene will offset losses from the drop in Combigene's long position.
The idea behind Genovis AB and Combigene AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance